NYAS Conferences
New York Academy of Sciences
left end
Search
divider divider feedback right end
Annals of the New York Academy of Sciences Annals of the New York Academy of Sciences login

Main

Browse Volumes

Forthcoming Volumes

Annals PrePrints

Annals Extra

E-mail Alerts

Subscriptions & Orders

New Proposals

Author Guidelines

About Annals

Help

Get free Annals volume as a NYAS member: http://www.nyas.org/annalsreaderhw
Issue 874 coverHEART IN STRESS Copyright © 1999 by the New York Academy of Sciences
description

This Volume
Table of Contents
Description
This Article
Full Text
Full Text (PDF)
Services
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Citing Articles
Citing Articles via HighWire
Citing Articles via Google Scholar
Google Scholar
Articles by KUMAR, D.
Articles by SINGAL, P.
Search for Related Content
PubMed
PubMed Citation
Articles by KUMAR, D.
Articles by SINGAL, P.
Annals of the New York Academy of Sciences 874:156-168 (1999)
© 1999 New York Academy of Sciences

Apoptosis in Isolated Adult Cardiomyocytes Exposed to Adriamycina

DINENDER KUMAR, LORRIE KIRSHENBAUM, TIMAO LI, IGOR DANELISEN AND PAWAN SINGALb

Institute of Cardiovascular Sciences, St. Boniface General Hospital Research Centre Department of Physiology, Faculty of Medicine, University of Manitoba, Winnipeg, R2H 2A6, Canada

aThis study was supported by a grant from the Manitoba Heart and Stroke Foundation. Dr. Kirshenbaum was supported by a scholarship from the Heart and Stroke Foundation of Canada and Dr. Singal by a salary award from the Medical Research Council of Canada.
bAddress correspondence to: Dr. Pawan K. Singal, Ph.D., D.Sc., F.A.C.C., Institute of Cardiovascular Sciences, St. Boniface General Hospital Research Centre, 351 Tache Avenue, Room R3022, Winnipeg, Manitoba R2H 2A6 Canada; Telephone: (204) 235-3416; Fax: (204) 233-6723; E-mail: psingal{at}sbrc.umanitoba.ca

Adriamycin (doxorubicin) is a highly potent antineoplastic agent, but its use is limited by the risk of developing cardiomyopathy and congestive heart failure. Available evidence suggests that adriamycin-induced congestive heart failure is mediated by oxidative stress. We examined the possibility of adriamycin-induced apoptosis in isolated adult rat cardiomyocytes and its inhibition by trolox, a water-soluble antioxidant. Cardiomyocytes isolated from rat hearts were exposed to 20 µM adriamycin for 1 h and examined at different post-treatment durations (0-23 h). Adriamycin caused a significant decrease in rod-shaped cells and an increase in round cells. Both Hoechst 33258 staining and TUNEL assay revealed a significantly increased number of apoptotic myocytes and nucleosomal fragmentation upon exposure to adriamycin. In agarose gel electrophoresis, DNA laddering was found to be more intense in adriamycin-exposed myocytes. A bright smear at the leading edge of the gels suggested indiscriminate fragmentation of DNA and myocyte necrosis by adriamycin. Both types of DNA degradations due to adriamycin were significantly reduced by trolox. We suggest that adriamycin-induced cell death involves both apoptosis and necrosis and these may be mediated by oxidative stress.




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. K. Singla, R. D. Singla, and D. E. McDonald
Factors released from embryonic stem cells inhibit apoptosis in H9c2 cells through PI3K/Akt but not ERK pathway
Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H907 - H913.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Montero, A. Morales, L. Llacuna, J. M. Lluis, O. Terrones, G. Basanez, B. Antonsson, J. Prieto, C. Garcia-Ruiz, A. Colell, et al.
Mitochondrial Cholesterol Contributes to Chemotherapy Resistance in Hepatocellular Carcinoma
Cancer Res., July 1, 2008; 68(13): 5246 - 5256.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
T. Banyasz, I. Lozinskiy, C. E. Payne, S. Edelmann, B. Norton, B. Chen, Y. Chen-Izu, L. T. Izu, and C. W. Balke
Transformation of adult rat cardiac myocytes in primary culture
Exp Physiol, March 1, 2008; 93(3): 370 - 382.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
A. Clerk, T. J. Kemp, G. Zoumpoulidou, and P. H. Sugden
Cardiac myocyte gene expression profiling during H2O2-induced apoptosis
Physiol Genomics, April 24, 2007; 29(2): 118 - 127.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. J. Chicco, C. M. Schneider, and R. Hayward
Voluntary exercise protects against acute doxorubicin cardiotoxicity in the isolated perfused rat heart
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2005; 289(2): R424 - R431.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. Lou, I. Danelisen, and P. K. Singal
Involvement of mitogen-activated protein kinases in adriamycin-induced cardiomyopathy
Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1925 - H1930.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. C. Childs, S. L. Phaneuf, A. J. Dirks, T. Phillips, and C. Leeuwenburgh
Doxorubicin Treatment in Vivo Causes Cytochrome c Release and Cardiomyocyte Apoptosis, As Well As Increased Mitochondrial Efficiency, Superoxide Dismutase Activity, and Bcl-2:Bax Ratio
Cancer Res., August 15, 2002; 62(16): 4592 - 4598.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
X. Liu, Z. Chen, C. C. Chua, Y.-S. Ma, G. A. Youngberg, R. Hamdy, and B. H. L. Chua
Melatonin as an effective protector against doxorubicin-induced cardiotoxicity
Am J Physiol Heart Circ Physiol, July 1, 2002; 283(1): H254 - H263.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
H. Roger Brown, Hong Ni, G. Benavides, L. Yoon, K. Hyder, J. Giridhar, G. Gardner, R. D. Tyler, and K. T. Morgan
Correlation of Simultaneous Differential Gene Expression in the Blood and Heart with Known Mechanisms of Adriamycin-Induced Cardiomyopathy in the Rat
Toxicol Pathol, June 1, 2002; 30(4): 452 - 469.
[Abstract] [PDF]


Home page
Pharmacol. Rev.Home page
A. Szewczyk and L. Wojtczak
Mitochondria as a Pharmacological Target
Pharmacol. Rev., March 1, 2002; 54(1): 101 - 127.
[Abstract] [Full Text] [PDF]



footerLeft footerRight